Haematology dilemma s to refer or not to refer?

Similar documents
GP Referral Guidelines. for. South Wales Cancer Network. Document Control Sheet. Specialty/Project Haematological Site Specific Group

HEFT Pathology Guideline. GP Investigation and Referral Pathways for leucocyte, platelet disturbances and polycythaemia

King s Health Partners Haematology Institute and Network GP Referral Guide, Adult Haematology

King s Health Partners Haematology Institute and Network GP Referral Guide, Adult Haematology

Western Health Specialist Clinics Access & Referral Guidelines

Abnormal blood counts in children Dr Tina Biss Consultant Paediatric Haematologist Newcastle upon Tyne Hospitals NHS Foundation Trust

Interpreting Blood Tests Part 1. Dr Andrew Smith

Borderline cytopenias. Dr Taku Sugai Consultant Haematologist

UH Bristol Haematology Referral Guidelines for Primary Care

Rory McCulloch. Specialty Trainee Haematology Royal Devon & Exeter Hospital

Haematological Cancer Suspected (Adults & Children)

Haematology for GP's

Michael Joffe ST6 Haematology SpR

GP CME. James Liang Consultant Haematologist. Created by: Date:

HYDROXYCARBAMIDE for Haematological conditions (Adults)

Management of Anaemia

Cytopaenias in HIV. Dr Maresce Bizaare Specialist Physician Clinical Haematology Fellow IALCH

Julie Ball SHOT Clinical Incidents Specialist

GP refresher course Anaemia. Peter MacCallum Consultant Haematologist Barts Health NHS Trust London January 2018

Anaemia / SCD/ Bleeding disorders in Children

Clinical & Laboratory Assessment

FBC interpretation. Dr. Gergely Varga

Southern Trust Anticoagulant Team

Morphology Case Study. Presented by Niamh O Donnell, BSc, MSc. Medical Scientist Haematology Laboratory Cork University Hospital

Complete Blood Count in Primary Care

Evaluation of Anemia. Md. Shafiqul Bari Associate professor (Medicine) SOMC

2. Liver blood tests and what they mean p2 Acute and chronic liver screen

Candidates must answer ALL questions

The sickle cell outpatient service Information for adult patients with sickle cell disease

North East Essex Medicines Management Committee

Common Haematological Problems in Primary Care

Approach to a pale child

Pre-operative Anaemia Colorectal and Orthopaedic Surgery

I. Definitions. V. Evaluation A. History B. Physical Exam C. Laboratory evaluation D. Bone marrow examination E. Specialty referrals

Anaemias and other Pesky Haematology Questions

Dr Banu Kaya Consultant Haematologist Barts Health NHS Trust Royal London Hospital, London, UK SICKLE CELL AND THALASSAEMIA OVERVIEW

DOAC and NOAC are terms for a novel class of directly acting oral anticoagulant drugs including Rivaroxaban, Apixaban, Edoxaban, and Dabigatran.

UNUSUAL PRESENTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS

Blood Transfusions in Children with Haemoglobinopathies

Types of Anaemias and their Management. S. Moncrieffe, Pharm.D., MPH, Dip.Ed., RPh. PSJ CE Mandeville Hotel April 27, 2014

Alister Jones Patient Blood Management Practitioner NHS Blood and Transplant

National Comparative Audit of red cell transfusion in Medical Patients Part Two

Chest diseases Hospital Hematology Patient care plans

Guidelines on the Management of a Child with Sickle Cell Disease and low Haemoglobin

Pathology Service User Guide Haematology

DIRECT ORAL ANTICOAGULANTS: WHEN TO USE, WHICH TO CHOOSE AND MANAGEMENT OF BLEEDING

2. Liver blood tests and what they mean p2 Acute and chronic liver screen

Symptoms and Signs in Hematology (2)/ 2013

General Characterisctics

Rivaroxaban film coated tablets are available in 2 strengths for this indication: 15mg and 20mg.

Platelet and WBC disorders

Hydroxyurea and Transfusion Therapy for the Treatment of Sickle Cell Disease

Acute painful crisis in patients with sickle cell disease: Clinical Guidelines (HN-506a)

Year 2003 Paper two: Questions supplied by Tricia

Greater Manchester Commissioning Hub: Cancer Programme. The ACE Programme. Wave 2 Multidisciplinary Diagnostic Centres

Tim R. Randolph. PhD, MT(ASCP) Chair and Associate Professor Department of Biomedical Laboratory Science Saint Louis University

HAEMATOLOGICAL EVALUATION OF ANEMIA. Sitalakshmi S Professor and Head Department of Clinical Pathology St John s medical College, Bangalore

The Irony of Anemia How to interpret the CBC

Guidelines on the Management of a Child with Sickle Cell Disease and low Haemoglobin

NORTH AND EAST DEVON HEALTHCARE COMMUNITY SHARED CARE PRESCRIBING GUIDELINE

POMALIDOMIDE AND LOW DOSE DEXAMETHASONE

High Intensity Chemotherapy Guidelines for Haematology Patients at ASPH

NHS North of Tyne Guidelines on Iron Deficiency Anaemia & Referral Form v2

Hydroxyurea (Hydroxycarbamide) - Guidelines for treating children with Sickle Cell Disease

Vitamin B12 treatment guideline

Department of Clinical Haematology

FBC CASES Vernon Louw Clinical Haematology 2010

Laboratory Empowerment. Debbie Asher Adrian Ebbs Transfusion Laboratory Managers, Eastern Pathology Alliance

Aneurin Bevan University Health Board Sickle Cell Anaemia and Haemoglobinopathy Screening and Management in Pregnancy Guidelines

Case scenarios in Pediatric Hematology and Oncology. Dr. Zainul Aabideen Consultant, Pediatric Hematology and Oncology Burjeel Hospital

Prescribing Framework for Methotrexate for Immunosuppression in ADULTS

Leukocytosis - Some Learning Points

Dr Charlie Baker Consultant Anaesthetist UHNM. Being a place our f amilies would choose

Chapter 3 Diseases of the Blood and Bloodforming Organs and Certain Disorders Involving the Immune Mechanism D50-D89

Joanne Mallon, Nora O Neill, Dr D Hull Antenatal midwife coordinator, Consultant Haematologist

Taking The Fear Out of Abnormal CBC s Problems of Production, Destruction or loss

Part 1 examination. Haematology: First paper. Tuesday 20 March Candidates must answer all questions. Each question is worth a total of 25 marks.

Primary Care Prescriber Information EDOXABAN (LIXIANA ) Treatment of acute venous thromboembolism and prevention of recurrent venous thromboembolism

Clinical Guidelines on the Use of Iron Chelation in Children Receiving Regular Blood Transfusions

IRON DEFICIENCY / ANAEMIA ANTHONY BEETON

Summary of Recommendation Statements Kidney International Supplements (2012) 2, ; doi: /kisup

Skin Pathway Group Alemtuzumab in Cutaneous Lymphoma

This is a controlled document and therefore must not be changed

Susan Stegman, MD Medical Director AXA Equitable Life May 3, 2016

Approach to the abnormal CBC

Approach to the child with anemia. Nittaya Wisanuyothin,MD. Pediatrics Department, Maharat Nakhonratchasima Hospital

UNDERSTANDING BLOOD TESTS

PREOPERATIVE PATIENT PREPARATION PROTOCOL

Anaemia in Pregnancy

Approach to Anemia PG CME

Shared Care Protocol for the Prescription and Supply of Low Molecular Weight Heparins

Interpreting the CBC. Robert Miller PA Assistant Professor of Clinical Pediatrics and Family Medicine USC Keck School of Medicine Retired

Guideline for the Acute Management of Stroke in Paediatric Patients with Sickle Cell Disease

Gaucher Disease: a multiorgan rare disease in Internal Medicine. M.Domenica Cappellini Fondazione Policlinico IRCCS University of Milan

Contents SECTION 1: PHYSIOLOGY OF BLOOD

NCCP Chemotherapy Protocol. Ponatinib Therapy

HERTFORDSHIRE MEDICINES MANAGEMENT COMMITTEE (HMMC) DABIGATRAN RECOMMENDED What it is Indications Date decision last revised

MYELOPROLIFARATIVE NEOPLASMS. Dr. Hasan Fahmawi, MRCP(UK), FRCP(Edin).

UNUSUAL PRESENTATION OF AN USUAL CAUSE OF THROMBOCYTOPENIA SOUTHERN RAILWAY HQ HOSPITAL, PERAMBUR DR. KUMARAN DNB PG

Edoxaban. Direct Xa inhibitor Direct thrombin inhibitor Direct Xa inhibitor Direct Xa inhibitor

Transcription:

Haematology dilemma s to refer or not to refer? NWL Pathology GP Study Day Dr Fatts Chowdhury Consultant Haematologist in Transfusion Medicine NHS Blood and Transplant Senior Honorary Clinical Lecturer Imperial College Healthcare NHS Trust St Marys Hospital 1 st Floor Cambridge Wing Praed Street London W2 1NY fateha.chowdhury@imperial.nhs.uk

Learning Objectives 1. Investigate and manage patients with an abnormal FBC indices 2. Discuss the indications for DOACs & how to initiate therapy 3. Understand the secondary causes of polycythaemia 4. How to investigate patients with high ferritin 5. Investigation of patients who may have a haemoglobinopathy 6. How and where to refer patients who may have lymphoma / myeloma

Anaemia Defined Hb <13g/dl Hb <11.5g/dl Look at MCV Look at RDW Careful history diet bleeding drugs family history Blood film and retics Ferritin / vitamin B12 / folate Serum iron / transferrin saturation (more informative in inflammatory states: iron replete if TSats >25-30%) Immunoglobulin / Serum & Urine Protein Electrophoresis U+E /LFT Monitor FBC for progression

?Iron Intolerant Check diet / compliance Treat side effects (laxatives, anti-emetics) reduce dose alternate days Try different preparations (tablets / liquids) Add Ascorbic acid 100mg tds Avoid concurrent tea / chapatti gap of 2hours Refer if Persistent unexplained anaemia Compliance not an issue Iron deficiency with suboptimal response to oral iron + ascorbic acid after 8weeks? Bleeding disorder i.e. vwd

Macrocytosis 1. ETOH 2. Diet 3. Drug Blood film Reticulocytes Liver / Thyroid function Vit B12 /folate (intrinsic factor antibodies & coeliac screen) Immunoglobulin / Serum Protein & Urine electrophoresis Raised MMA reflects reduced B12 Vit B12 >300pg/ml adequate stores Urgent Routine Do not refer Suspected MDS based on blood film report (send to HH) MCV >100 + cytopenia (excluded B12/folate deficiency Persistent unexplained MCV >105fL Uncomplicated Vit B12 / folate deficiency Hydroxycobalamin 1mg IM x6 injections over 2 weeks, then 3 monthly Cyanocobalamin 100mcg orally

Neutropenia Blood film Autoimmune screen Viral infections repeat in 4 weeks Drugs stop offending drug if symptoms of infection / recurrent infections Urgent Routine Do not refer Neutrophils < 1.0 - Recurrent infections - Has fever needs IV antibiotic send to A+E Neutrophils <1.0 in association with other Cytopenias Hepatosplenomegaly lymphadenopathy Neutrophils <2.0 Recurrent infections (> 3 in 6 months) Asymptomatic patients from Middle East Africa Afro Caribbean

Thrombocytopenia Blood film (bleep 9071 Lab SpR) Exclude excessive ETOH / drugs Check / iron studies/ vitb12 / folate /HIV/ hepatitis serology /Autoimmune screen H Pylori in stool antigen - treat & repeat FBC in 4 weeks Immediate Urgent Routine Platelet <20 Platelet <50 Persistent platelet > 50 and stable and no cause found Platelet <50 and bleeding or excessive bruising Platelet 50-100 in association with anaemia/ leukopenia /splenomegaly / lymphadenopathy Pregnancy Surgery planned History of thrombosis

Leucocytosis Ask for blood film, (bleep 9071 Lab SpR) Exclude hepato-splenomegaly & lymphadenopathy Immediate Urgent Routine Do not refer Suspected new leukaemia Leucoerythroblastic film Persistent raised wbc >20 Neut >15 Mono>1.5 Eo >1.5 Basophilia High Wbc: infection (acute or chronic) Malignancy Smoker Inflammatory disease New CML Wbc >100 Hyperviscosity symptoms New CML Wbc 30-50 If on steriods Unexplained wbc > 50

Lab SpR Blp 9071 All Haem-Onc Referrals Hammersmith Hospital

Indication for DOAC Non valvular AF with >1 risk factors DVT / PE egfr >30mls/min/1.73m 2 Risk Factors Prior stroke / TIA Age 75 HT DM Symptomatic HF (NYHA class II) Rivaroxaban AF 20mg daily 5mg BD Apixaban (>80yrs, body wt <60 kg, high bleeding risk, Cr >133 umol/l) DVT /PE Prevention of recurrent VTE Prevention of VTE in Hip Sx Knee Sx 15mg BD for 21 days, then 20mg (15mg od if egfr<50) ----------------------------------- - 10mg OD for 35/7 10mg OD for 14/7 10mg BD for 7 days, then 5mg BD 2.5mg BD 2.5mg BD 32-38 days 2.5mg BD 10-14 days

DOAC Initiation Use referral form Seen within a week next available slot Site Monday St Marys Hospital AM new pts Tuesday Wednesday St Charles Hospital Queens Park Healthcare centre Thursday St Marys Hospital AM new pts Friday Admin / MDT

Polycythaemia History: Smoking (tobacco or shisha) Dehydration ETOH excess Thiazides diuretics / antiht drugs Screen for diabetes Check FBC on un-cuffed sample after patient has drunk 1.5L water Urgent Routine Do not refer Male PCV >0.6 Female PCV > 0.54 In absence of congenital heart disease Male PCV 0.51 Female PCV 0.48 In association of recent arterial or venous thrombosis, neurological symptoms, bleeding, visual loss Persistent Male PCV 0.51 Female PCV 0.48 In association splenomegaly pruritus high wbc / platelets Dehydration Excess ETOH / smoking Drug related (thiazides etc.) Cyanosis heart disease

High Ferritin Check family history Haemochromatosis Check serum iron and transferrin saturation on fasting sample Exclude fatty liver / inflammation/ infection/ liver disease/ ETOH excess/ Malignancy Urgent Routine Do not refer Transferrin saturation >50% with unexplained end organ damage Diabetes Congestive cardiac failure Hypogonadism Liver dysfunction Transferrin saturation >50% on repeat fasting sample and no evidence of end organ damage If Transferrin saturation < 50% and no FH for Haemochromatosis

Haemoglobinopathy Check family history Sickle cell/ Thalassemia /G6PD deficiency Check blood film Haemoglobinopathy screen Urgent referral Routine referral Do not refer Acute sickle crisis- A+E Thalassemia intermedia Alpha Thalassemia trait with normal Hb Thalassemia Major Hereditary Spherocytosis / G6PD / Pyruvate Kinase deficiency with Hb >80g/l Beta Thalassemia Trait with normal Hb Hereditary Spherocytosis or Elliptocytosis / G6PD / Pyruvate Kinase deficiency with Hb < 75g/l HbSS / HbSC / HSbeta Thalassemia - well

All Haem-Onc Referrals Hammersmith Hospital Surgeons Mr Tolley Mr Ziprin

All Haem-Onc Referrals Hammersmith Hospital Haematology SpR Blp 9077 Blp 9068

Summary 1. Investigate and manage patients with an abnormal FBC indices 2. Discuss the indications for DOACs & how to initiate therapy 3. Understand the secondary causes of polycythaemia 4. How to investigate patients with high ferritin 5. Investigation of patients who may have a haemoglobinopathy 6. How and where to refer patients who may have lymphoma / myeloma

????????? haematologyadvice.imperial@nhs.net